Clarithromycin - ≥95% (HPLC), high purity , CAS No.81103-11-9

7 Citations
Item Number
C434242
Grouped product items
SKUSizeAvailabilityPrice Qty
C434242-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$58.90
C434242-250mg
250mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$132.90
C434242-1g
1g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$477.90

Basic Description

Synonyms6-O-methyl erythromycin | CLARITHROMYCIN (USP IMPURITY) | CLARITHROMYCIN [INN] | DTXCID40820062 | 8-Hydroxy-3,4-dihydrocarbstyril | CAS-81103-11-9 | Clacee | Bicrolid | Boc-Leu-OH.H2O | CLARITHROMYCIN (USP-RS) | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S
Specifications & PurityMoligand™, ≥95%(HPLC)
Biochemical and Physiological MechanismsClarithromycin inhibits bacterial protein synthesis by binding to the bacterial 50S ribosomal subunit. Binding inhibits peptidyl transferase activity and interferes with amino acid translocation. Clarithromycin is first metabolized to 14-OH clarithromyci
GradeMoligand™
Product Description

General Description

Chemical structure: macrolide


Application

Clarithromycin is a semisynthetic macrolide antibiotic that is derived from erythromycin. Clarithromycin may be bacteriostatic or bactericidal depending on the organism and drug concentration . Clarithromycin may be used to attenuate cardiac transplantation rejection via matrix metalloproteinase suppression. Clarithromycin has been used to study inflammatory markers in chronic obstructive pulmonary disease (COPD). It is used to study bacterial protein synthesis and peptide translation.


Other Notes

Keep container tightly closed in a dry and well-ventilated place. Keep in a dry place.

Associated Targets(Human)

CTH Tchem Cystathionine gamma-lyase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CYP1A2 Tchem Cytochrome P450 1A2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD2 Tclin D(2) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD4 Tchem D(4) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CYP3A4 Tclin Cytochrome P450 3A4 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ERBB2 Tclin Receptor tyrosine-protein kinase erbB-2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ELANE Tclin Neutrophil elastase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
EGFR Tclin Epidermal growth factor receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AVPR1A Tclin Vasopressin V1a receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HMGCR Tclin 3-hydroxy-3-methylglutaryl-coenzyme A reductase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HDAC6 Tclin Histone deacetylase 6 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HRH1 Tclin Histamine H1 receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLCO1B3 Tchem Solute carrier organic anion transporter family member 1B3 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC6A3 Tclin Sodium-dependent dopamine transporter (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC6A4 Tclin Sodium-dependent serotonin transporter (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SIGMAR1 Tclin Sigma non-opioid intracellular receptor 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE4D Tclin cAMP-specific 3',5'-cyclic phosphodiesterase 4D (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PTGS1 Tclin Prostaglandin G/H synthase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CA2 Tclin Carbonic anhydrase 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD3 Tclin D(3) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA2B Tclin Alpha-2B adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA2C Tclin Alpha-2C adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2A Tclin 5-hydroxytryptamine receptor 2A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA2A Tclin Adenosine receptor A2a (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ACHE Tclin Acetylcholinesterase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA1B Tclin Alpha-1B adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA1A Tclin Alpha-1A adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AR Tclin Androgen receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MAOA Tclin Amine oxidase [flavin-containing] A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AKR1B1 Tclin Aldose reductase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA1 Tclin Adenosine receptor A1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR1A Tclin 5-hydroxytryptamine receptor 1A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA3 Tchem Adenosine receptor A3 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR6 Tchem 5-hydroxytryptamine receptor 6 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2B Tclin 5-hydroxytryptamine receptor 2B (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
F2 Tclin Prothrombin (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
EDNRA Tclin Endothelin-1 receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRD1 Tclin Delta-type opioid receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRK1 Tclin Kappa-type opioid receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRM1 Tclin Mu-type opioid receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NOS2 Tchem Nitric oxide synthase, inducible (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TACR1 Tclin Substance-P receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NOS1 Tchem Nitric oxide synthase, brain (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CALCR Tclin Calcitonin receptor (2215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR4 Tclin Serotonin 4 (5-HT4) receptor (2068 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Tclin Estrogen receptor beta (9272 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mc4r Melanocortin receptor 4 (1205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ltc4s Leukotriene C4 synthase (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sigmar1 Sigma opioid receptor (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcb1b P-glycoprotein 1 (174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mmp9 Matrix metalloproteinase 9 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcb1a P-glycoprotein 3 (492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus (3973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus pneumoniae (31063 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus (1748 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chlamydia pneumoniae (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Campylobacter jejuni (634 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Helicobacter pylori (3113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Burkholderia cepacia (649 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacter cloacae (7976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Proteus vulgaris (5823 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhimurium (15756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella flexneri (1836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Haemophilus (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pasteurella multocida (1166 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacteroides fragilis (1445 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Peptoniphilus asaccharolyticus (368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Peptostreptococcus anaerobius (347 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Micrococcus luteus (7463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus haemolyticus (1695 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus hominis (482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Moraxella catarrhalis (3334 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Neisseria meningitidis (411 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Citrobacter freundii (1864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella oxytoca (929 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Proteus mirabilis (3894 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhi (4293 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serratia marcescens (3237 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Haemophilus influenzae (8812 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chlamydia trachomatis (699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Finegoldia magna (323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus (1598 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus sp. (212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
INCHI InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1
InChi Key AGOYDEPGAOXOCK-KCBOHYOISA-N
Canonical SMILES CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
Isomeric SMILES CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
WGK Germany 3
RTECS KF4997000
Alternate CAS 81103-11-9,116836-41-0
PubChem CID 84029
NSC Number 758704
MeSH Entry Terms 6-O-Methylerythromycin;A 56268;A-56268;A56268;Biaxin;Clarithromycin;TE 031;TE-031;TE031
Molecular Weight 747.95

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

Specific Rotation[α]-92°C
Melt Point(°C)225°C

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H302:Harmful if swallowed

Precautionary Statements

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P330:Rinse mouth.

P301+P317:IF SWALLOWED: Get medical help.

WGK Germany 3
RTECS KF4997000
Merck Index 2339

Related Documents

Citations of This Product

1. Xiaoyu Zhang, Peiran Meng, Wei Wang, Xiwen Li, Zuan Yang, Shaokai Du, Yue Sun.  (2023)  Simultaneous Electrochemical Determination of Erythromycin and Hemoglobin by Flexible Carbon Cloth Modified with ZnO Nanorod Arrays and Au Nanoparticles by Differential Pulse Voltammetry (DPV).  ANALYTICAL LETTERS,      [PMID:]
2. Qin Tang, Zhengcai Ma, Xiang Tang, Yan Liu, Huimin Wu, Yu Peng, Baihua Jiao, Rui Wang, Xiaoli Ye, Hang Ma, Xuegang Li.  (2023)  Coptisine inhibits Helicobacter pylori and reduces the expression of CagA to alleviate host inflammation in vitro and in vivo.  JOURNAL OF ETHNOPHARMACOLOGY,    (116618).  [PMID:37164257]
3. Ruoyu Deng, Dongxu Yang, Mengli Chen, Qiang He, Qingjuan He, Yi Chen.  (2023)  The enhancing energy efficiency of sulfadiazine degradation using a DBD-contact plasma treatment process.  CHEMICAL ENGINEERING JOURNAL,  463  (142491).  [PMID:]
4. Chong Yu, Chi Li, Ying Zhang, Xiang Du, Jing-Han Wang, Zhan-You Chi, Qian Zhang.  (2023)  Effects of environment-relevant concentrations of antibiotics on seawater Chlorella sp. biofilm in artificial mariculture effluent.  Algal Research-Biomass Biofuels and Bioproducts,  70  (103008).  [PMID:]
5. Yu Wang, Yunxiang He, Qin Wang, Xiaoling Wang, Blaise L. Tardy, Joseph J. Richardson, Orlando J. Rojas, Junling Guo.  (2023)  Microporous membranes for ultrafast and energy-efficient removal of antibiotics through polyphenol-mediated nanointerfaces.  Matter,  (260-273).  [PMID:]
6. Wan-Feng Xu, Yun Wang, Hai Huang, Jia-Wei Wu, Yuan Che, Chu-Jie Ding, Quan Zhang, Wei-Ling Cao, Li-Juan Cao.  (2022)  Octreotide-based therapies effectively protect mice from acute and chronic gastritis.  EUROPEAN JOURNAL OF PHARMACOLOGY,  928  (174976).  [PMID:35487253]
7. Ling Li, Yaoyao Du, Yang Wang, Ning He, Bing Wang, Tong Zhang.  (2022)  Atractylone Alleviates Ethanol-Induced Gastric Ulcer in Rat with Altered Gut Microbiota and Metabolites.  Journal of Inflammation Research,      [PMID:35996682]

References

1. Jerry M Zuckerman.  (2004-08-17)  Macrolides and ketolides: azithromycin, clarithromycin, telithromycin..  Infectious disease clinics of North America,  18  ((3)): (621-649).  [PMID:15308279]
2. Toru Egashira.  (2006-03-22)  [Development and clinical application of invader assay--detection of resistant mutation to clarithromycin in Helicobacter pylori]..  Rinsho byori. The Japanese journal of clinical pathology,  54  ((2)): (176-183).  [PMID:16548239]
3. Jerry M Zuckerman,Fozia Qamar,Bartholomew R Bono.  (2009-11-17)  Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline..  Infectious disease clinics of North America,  23  ((4)): (997-1026).  [PMID:19909895]
4. Li Jing Xiong,Yu Tong,Zhiling Wang,Meng Mao.  (2012-10-17)  Detection of clarithromycin-resistant Helicobacter pylori by stool PCR in children: a comprehensive review of literature..  Helicobacter,  18  ((2)): (89-101).  [PMID:23067446]
5. Douglas R Morgan,Javier Torres,Rachael Sexton,Rolando Herrero,Eduardo Salazar-Martínez,E Robert Greenberg,Luis Eduardo Bravo,Ricardo L Dominguez,Catterina Ferreccio,Eduardo C Lazcano-Ponce,Maria Mercedes Meza-Montenegro,Edgar M Peña,Rodolfo Peña,Pelayo Correa,María Elena Martínez,William D Chey,Manuel Valdivieso,Garnet L Anderson,Gary E Goodman,John J Crowley,Laurence H Baker.  (2013-02-14)  Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities..  JAMA,  309  ((6)): (578-586).  [PMID:23403682]
6. Taghi Naserpour Farivar,Reza Najafipour,Pouran Johari.  (2013-02-14)  Prevalence of clarithromycin-resistant Helicobacter pylori in patients with chronic tonsillitis by allele-specific Scorpion real-time polymerase chain reaction assay..  The Laryngoscope,  123  ((6)): (1478-1482).  [PMID:23404672]
7. Edyta Szałek,Agnieszka Karbownik,Wojciech Połom,Marcin Matuszewski,Katarzyna Sobańska,Hanna Urjasz,Tomasz Grabowski,Anna Wolc,Edmund Grześkowiak.  (2013-02-15)  Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not?.  Pharmacological reports : PR,  64  ((6)): (1554-1559).  [PMID:23406766]
8. Muhammad Amin,Farooq Anwar,Fauqia Naz,Tahir Mehmood,Nazamid Saari.  (2013-02-26)  Anti-Helicobacter pylori and urease inhibition activities of some traditional medicinal plants..  Molecules (Basel, Switzerland),  18  ((2)): (2135-2149).  [PMID:23434867]
9. Jotam G Pasipanodya,Tawanda Gumbo.  (2013-03-05)  Drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions..  American journal of respiratory and critical care medicine,  187  ((5)): (554-555).  [PMID:23457368]
10. Lucy E Cottle,Effrossyni Gkrania-Klotsas,Hannah J Williams,Hannah E Brindle,Andrew J Carmichael,Graham Fry,Nicholas J Beeching.  (2013-03-08)  A multinational outbreak of histoplasmosis following a biology field trip in the Ugandan rainforest..  Journal of travel medicine,  20  ((2)): (83-87).  [PMID:23464714]
11. P Malfertheiner.  (2013-03-21)  [Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance]..  Deutsche medizinische Wochenschrift (1946),  138  ((13)): (628-628).  [PMID:23512360]
12. Stuart Schembri,Peter A Williamson,Philip M Short,Aran Singanayagam,Ahsan Akram,Joanne Taylor,Anika Singanayagam,Adam T Hill,James D Chalmers.  (2013-03-26)  Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies..  BMJ (Clinical research ed.),  346  (f1235-f1235).  [PMID:23525864]
13. Alicia C Marin,Adrian G McNicholl,Javier P Gisbert.  (2013-03-30)  A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)..  Expert opinion on pharmacotherapy,  14  ((7)): (843-861).  [PMID:23537368]
14. Javier Molina.  (2013-04-30)  [Update on the efficacy of triple therapy for Helicobacter pylori infection and clarithromycin resistance rates in Spain (2007-2012)]..  Gastroenterologia y hepatologia,  36  ((6)): (375-381).  [PMID:23623461]
15. Adrian G McNicholl,Alicia C Marin,Javier Molina-Infante,Manuel Castro,Jesús Barrio,Julio Ducons,Xavier Calvet,Cristobal de la Coba,Miguel Montoro,Felipe Bory,Angeles Perez-Aisa,Montserrat Forné,Javier P Gisbert.  (2013-05-15)  Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice..  Gut,  63  ((2)): (244-249).  [PMID:23665990]
16. Jorge-Shmuel Delgado,Euvgeni Landa,David Ben-Dor.  (2013-07-26)  Granulomatous gastritis and Helicobacter pylori infection..  The Israel Medical Association journal : IMAJ,  15  ((6)): (317-318).  [PMID:23882902]
17. Abolfazl Zendedel,Farideh Moradimoghadam,Vahid Almasi,Hamidreza Zivarifar.  (2013-08-07)  Antibiotic resistance of Helicobacter pylori in Mashhad, Iran..  JPMA. The Journal of the Pakistan Medical Association,  63  ((3)): (336-339).  [PMID:23914633]
18. Maliheh Shahbazi Niaz,Daniela Traini,Paul M Young,Maliheh Ghadiri,Ramin Rohanizadeh.  (2013-10-08)  Investigation into physical-chemical variables affecting the manufacture and dissolution of wet-milled clarithromycin nanoparticles..  Pharmaceutical development and technology,  19  ((8)): (911-921).  [PMID:24093825]
19. Francesco Drago,Arianna Fay Agnoletti,Aurora Parodi.  (2013-10-16)  Acute autoimmune thrombocytopenia and worsening of dermatomyositis after administration of clarithromycin..  Journal of the American Academy of Dermatology,  69  ((5)): (e267-e268).  [PMID:24124859]
20. Sonja Gandhi,Jamie L Fleet,David G Bailey,Eric McArthur,Ron Wald,Faisal Rehman,Amit X Garg.  (2013-12-19)  Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury..  JAMA,  310  ((23)): (2544-2553).  [PMID:24346990]
21. S-Y Kim,W-J Koh,H Y Park,K Jeon,O J Kwon,S-N Cho,S J Shin.  (2013-12-21)  Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease..  Clinical and experimental immunology,  176  ((1)): (93-101).  [PMID:24354934]
22. Ibrahim Anwar Hassounah,Nader Abdelmonem Shehata,Gade Carolyn Kimsawatde,Amanda Gayle Hudson,Nammalwar Sriranganathan,Eugene Gregory Joseph,Roop L Mahajan.  (2014-01-01)  Studying the activity of antitubercluosis drugs inside electrospun polyvinyl alcohol, polyethylene oxide, and polycaprolacton nanofibers..  Journal of biomedical materials research. Part A,  102  ((11)): (4009-4016).  [PMID:24376010]
23. Yanhong Li,Tingting Su,Yan Zhang,Xingliang Huang,Jing Li,Chong Li.  (2014-01-30)  Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant Staphylococcus aureus infection..  Drug delivery,  22  ((5)): (627-637).  [PMID:24471983]
24. Chun-Taek Oh,Cheol Moon,Ok Kyu Park,Seung-Hae Kwon,Jichan Jang.  (2014-02-13)  Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model..  The Journal of antimicrobial chemotherapy,  69  ((6)): (1599-1607).  [PMID:24519481]
25. Keisuke Nakase,Hidemasa Nakaminami,Yuko Takenaka,Nobukazu Hayashi,Makoto Kawashima,Norihisa Noguchi.  (2014-02-14)  Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan..  Journal of medical microbiology,  63  ((Pt 5)): (721-728).  [PMID:24523159]
26. Tran Thanh Binh,Seiji Shiota,Rumiko Suzuki,Miyuki Matsuda,Tran Thi Huyen Trang,Dong Hyeon Kwon,Shun Iwatani,Yoshio Yamaoka.  (2014-03-22)  Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing..  The Journal of antimicrobial chemotherapy,  69  ((7)): (1796-1803).  [PMID:24648504]
27. Guan Liu,Gui-Rong Wang,Xia Yu,Qian Liang,Jing Mu,Yuan-Yuan Shang,Ying Ling,Hai-Qing Zhang,Su-Hua Zheng,Hai-Rong Huang.  (2014-05-27)  Bacteriological characterization of a Mycobacterium parascrofulaceum strain isolated from a Chinese pneumonia patient..  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,  25  (82-87).  [PMID:24858903]
28. John Fowler,Steven D Mahlen.  (2014-07-31)  Localized cutaneous infections in immunocompetent individuals due to rapidly growing mycobacteria..  Archives of pathology & laboratory medicine,  138  ((8)): (1106-1109).  [PMID:25076301]
29. Hyo-Ji Kim,Kyung-Ah Seo,Hyun-Mi Kim,Eun-Sook Jeong,Jong Lyul Ghim,Seung Heon Lee,Young Min Lee,Dong Hyun Kim,Jae-Gook Shin.  (2014-09-15)  Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry..  Journal of pharmaceutical and biomedical analysis,  102  (9-16).  [PMID:25218029]
30. Kyu-Hyun Yoon,Sung Woon Park,Sang Wook Lee,Beom Jin Kim,Jae Gyu Kim.  (2014-09-24)  Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea..  Journal of Korean medical science,  29  ((9)): (1240-1246).  [PMID:25246742]
31. R Siekmeier,T Hofmann,G Scheuch.  (2014-09-26)  Inhalation of macrolides: a novel approach to treatment of pulmonary infections..  Advances in experimental medicine and biology,  839  (13-24).  [PMID:25252902]
32. Jin-Eung Kim,Min-Soo Kim,Yeo-Sang Yoon,Myung-Jun Chung,Do-Young Yum.  (2014-10-04)  Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection..  Journal of microbiology (Seoul, Korea),  52  ((11)): (955-962).  [PMID:25277407]
33. Nynke G L Jager,Hilde Rosing,Jan H M Schellens,Jos H Beijnen.  (2014-11-12)  Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review..  Bioanalysis,  ((18)): (2481-2514).  [PMID:25384597]
34. Yehia El-Garem,Mohamed El-Sawy,Taymour Mostafa.  (2014-11-30)  Seminal Helicobacter pylori treatment improves sperm motility in infertile asthenozoospermic men..  Urology,  84  ((6)): (1347-1350).  [PMID:25432826]
35. Michael Selgrad,Ina Tammer,Cosima Langner,Jan Bornschein,Julia Meißle,Arne Kandulski,Mariya Varbanova,Thomas Wex,Dirk Schlüter,Peter Malfertheiner.  (2014-12-05)  Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection..  World journal of gastroenterology,  20  ((43)): (16245-16251).  [PMID:25473179]
36. Fen Jiang,Hae-Deun Kim,Han-Sung Na,Seok-Yong Lee,Doo-Won Seo,Jong-Yeol Choi,Ji-Hye Ha,Hee-Jung Shin,Young-Hoon Kim,Myeon-Woo Chung.  (2014-12-17)  The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes..  Psychopharmacology,  232  ((11)): (1899-1909).  [PMID:25510856]
37. Matthew E Falagas,Apostolos K A Karagiannis,Theodora Nakouti,Giannoula S Tansarli.  (2015-01-07)  Compliance with once-daily versus twice or thrice-daily administration of antibiotic regimens: a meta-analysis of randomized controlled trials..  PloS one,  10  ((1)): (e0116207-e0116207).  [PMID:25559848]
38. Claire Andréjak,Deepak V Almeida,Sandeep Tyagi,Paul J Converse,Nicole C Ammerman,Jacques H Grosset.  (2015-01-28)  Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations..  Antimicrobial agents and chemotherapy,  59  ((4)): (2129-2135).  [PMID:25624335]
39. Raffaele Rauso.  (2015-05-09)  5-year study of a polyacrylamide hydrogel-based filler for rehabilitation of HIV-related facial lipoatrophy..  Aesthetic surgery journal,  35  ((8)): (1021-1029).  [PMID:25953480]
40. Jayaram Lakshmaiah Narayana,Han-Ning Huang,Chang-Jer Wu,Jyh-Yih Chen.  (2015-05-24)  Efficacy of the antimicrobial peptide TP4 against Helicobacter pylori infection: in vitro membrane perturbation via micellization and in vivo suppression of host immune responses in a mouse model..  Oncotarget,  ((15)): (12936-12954).  [PMID:26002554]
41. Yuping Yuan,Qinyi Wu,Guoxiang Cheng,Xuefang Liu,Siguo Liu,Juan Luo,Aimin Zhang,Li Bian,Jianquan Chen,Jiajun Lv,Xiangqian Dong,Gang Yang,Yunzhen Zhu,Lanqing Ma.  (2015-06-18)  Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori..  International journal of molecular medicine,  36  ((2)): (363-368).  [PMID:26080893]
42. Darley Maria Oliveira,Fernanda Germano Melo,Sikiru Olaitan Balogun,Adriana Flach,Edineide Cristina Alexandre de Souza,Gilmar Prado de Souza,Iolanda do Nascimento Araújo Rocha,Luiz Antonio Mendonça Alves da Costa,Ilsamar Mendes Soares,Larissa Irene da Silva,Sérgio Donizeti Ascêncio,Domingos Tabajara de Oliveira Martins.  (2015-06-24)  Antibacterial mode of action of the hydroethanolic extract of Leonotis nepetifolia (L.) R. Br. involves bacterial membrane perturbations..  Journal of ethnopharmacology,  172  (356-363).  [PMID:26102550]
43. Pablo Antonio Maia de Farias,Fernando Gomes Figueredo,Aline Maria Brito Lucas,Rafael Barbosa de Moura,Henrique Douglas Melo Coutinho,Tania Maria Sarmento da Silva,Ana Luiza de Aguiar Rocha Martin,Marta Maria de França Fon.  (2015-06-26)  Antibiotic-modifying activity of riachin, a non-cyanogenic cyanoglycoside extracted from Bauhinia pentandra..  Drug design, development and therapy,  (3067-3072).  [PMID:26109849]
44. Frantiescoli Dimer,Cristiane de Souza Carvalho-Wodarz,Jörg Haupenthal,Rolf Hartmann,Claus-Michael Lehr.  (2015-06-27)  Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections..  Pharmaceutical research,  32  ((12)): (3850-3861).  [PMID:26113237]
45. Guido A Gualdoni,Tilman Lingscheid,Klaus G Schmetterer,Annika Hennig,Peter Steinberger,Gerhard J Zlabinger.  (2015-07-15)  Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation..  Scientific reports,  (12016-12016).  [PMID:26152605]
46. Mònica Escolà Casas,Ravi Kumar Chhetri,Gordon Ooi,Kamilla M S Hansen,Klaus Litty,Magnus Christensson,Caroline Kragelund,Henrik R Andersen,Kai Bester.  (2015-07-15)  Biodegradation of pharmaceuticals in hospital wastewater by staged Moving Bed Biofilm Reactors (MBBR)..  Water research,  83  (293-302).  [PMID:26164801]
47. Frédéric Peyrusson,Deborah Butler,Paul M Tulkens,Françoise Van Bambeke.  (2015-07-15)  Cellular pharmacokinetics and intracellular activity of the novel peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus laboratory and clinical strains with various resistance phenotypes: studies with human THP-1 monocytes and J774 murine macrophages..  Antimicrobial agents and chemotherapy,  59  ((9)): (5747-5760).  [PMID:26169402]
48. Ana R Ribeiro,Marta Pedrosa,Nuno F F Moreira,Manuel F R Pereira,Adrián M T Silva.  (2015-10-04)  Environmental friendly method for urban wastewater monitoring of micropollutants defined in the Directive 2013/39/EU and Decision 2015/495/EU..  Journal of chromatography. A,  1418  (140-149).  [PMID:26431860]
49. Ilknur Basyigit,Fusun Yildiz,Sevgiye Kacar Ozkara,Elif Yildirim,Hasim Boyaci,Ahmet Ilgazli.  (2004-07-15)  The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data..  The Annals of pharmacotherapy,  38  ((9)): (1400-1405).  [PMID:15252191]
50. Mark H Gotfried.  (2004-10-16)  Clarithromycin (Biaxin) extended-release tablet: a therapeutic review..  Expert review of anti-infective therapy,  ((1)): (9-20).  [PMID:15482099]
51. Tetsuya Mine,Masashi Matsushima.  (2005-12-21)  [Recent topics on important drugs for H. pylori eradication: Clarithromycin (CAM)]..  Nihon rinsho. Japanese journal of clinical medicine,  63 Suppl 11  (372-375).  [PMID:16363562]
52. Ozlem Yilmaz,Ebru Demiray.  (2007-02-06)  Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy..  World journal of gastroenterology,  13  ((5)): (671-675).  [PMID:17278188]
53. Nabil M Mansour,Jana G Hashash,Mustapha El-Halabi,Ola Ghaith,Karim Maasri,Ismail Sukkarieh,Ahmad Malli,Ala I Sharara.  (2011-08-04)  A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection..  European journal of gastroenterology & hepatology,  23  ((10)): (865-870).  [PMID:21811161]
54. Javed Yakoob,Shahab Abid,Wasim Jafri,Zaigham Abbas,Khalid Mumtaz,Saeed Hamid,Rashida Ahmed.  (2013-02-26)  Low rate of recurrence of Helicobacter pylori infection in spite of high clarithromycin resistance in Pakistan..  BMC gastroenterology,  13  (33-33).  [PMID:23433429]
55. Won-Jung Koh,Byeong-Ho Jeong,Kyeongman Jeon,Soo-Youn Lee,Sung Jae Shin.  (2013-04-12)  Reply: drug concentration monitoring in Mycobacterium avium lung disease: problems with methods and conclusions..  American journal of respiratory and critical care medicine,  187  ((5)): (555-556).  [PMID:23577353]
56. Hiroki Kato,Yasushi Onishi,Yoko Okitsu,Yuna Katsuoka,Tohru Fujiwara,Noriko Fukuhara,Kenichi Ishizawa,Masanori Takagawa,Hideo Harigae.  (2013-04-30)  Addition of clarithromycin to lenalidomide/low-dose dexamethasone was effective in a case of relapsed myeloma after long-term use of lenalidomide..  Annals of hematology,  92  ((12)): (1711-1712).  [PMID:23625297]
57. Shamira J Shallom,Paul J Gardina,Timothy G Myers,Yinong Sebastian,Patricia Conville,Leslie B Calhoun,Hervé Tettelin,Kenneth N Olivier,Gulbu Uzel,Elizabeth P Sampaio,Steven M Holland,Adrian M Zelazny.  (2013-06-28)  New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identifying Mycobacterium massiliense isolates with inducible clarithromycin resistance..  Journal of clinical microbiology,  51  ((9)): (2943-2949).  [PMID:23804391]
58. Jamshid Vafaeimanesh,Mojgan Jalalzadeh,Morteza Nazarian.  (2014-01-18)  Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients..  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,  25  ((1)): (53-57).  [PMID:24434382]
59. Liya Zhou,Jianzhong Zhang,Minhu Chen,Xiaohua Hou,Zhaoshen Li,Zhiqiang Song,Lihua He,Sanren Lin.  (2014-03-20)  A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial..  The American journal of gastroenterology,  109  ((4)): (535-541).  [PMID:24642580]
60. Nilanjan Ghosh,Noah Tucker,Marianna Zahurak,Jocelyn Wozney,Ivan Borrello,Carol Ann Huff.  (2014-04-12)  Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma..  American journal of hematology,  89  ((8)): (E116-E120).  [PMID:24723438]
61. Chieh-Yu Pan,Jian-Chyi Chen,Jenn-Feng Sheen,Tai-Lang Lin,Jyh-Yih Chen.  (2014-05-14)  Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsis..  Antimicrobial agents and chemotherapy,  58  ((8)): (4264-4274).  [PMID:24820078]
62. Sungmo Jung,Chan Hyuk Park,Eun Hye Kim,Su Ji Shin,Hyunsoo Chung,Hyuk Lee,Jun Chul Park,Sung Kwan Shin,Yong Chan Lee,Sang Kil Lee.  (2014-08-05)  Preventing metachronous gastric lesions after endoscopic submucosal dissection through Helicobacter pylori eradication..  Journal of gastroenterology and hepatology,  30  ((1)): (75-81).  [PMID:25088761]
63. Chung-Su Park,Su-Mi Lee,Chang-Hwan Park,Han-Ra Koh,Chung-Hwan Jun,Seon-Young Park,Wan-Sik Lee,Young-Eun Joo,Hyun-Soo Kim,Sung-Kyu Choi,Jong-Sun Rew.  (2014-08-06)  Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance..  The American journal of gastroenterology,  109  ((10)): (1595-1602).  [PMID:25091062]
64. Barbara A Brown-Elliott,Kimberly Hanson,Sruthi Vasireddy,Elena Iakhiaeva,Kevin A Nash,Ravikiran Vasireddy,Nicholas Parodi,Terry Smith,Martha Gee,Anita Strong,Adam Barker,Samuel Cohen,Haleina Muir,E Susan Slechta,Richard J Wallace.  (2015-01-09)  Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility..  Journal of clinical microbiology,  53  ((3)): (875-878).  [PMID:25568437]
65. Nathalie M Vandevelde,Paul M Tulkens,Giulio G Muccioli,Françoise Van Bambeke.  (2015-02-26)  Modulation of the activity of moxifloxacin and solithromycin in an in vitro pharmacodynamic model of Streptococcus pneumoniae naive and induced biofilms..  The Journal of antimicrobial chemotherapy,  70  ((6)): (1713-1726).  [PMID:25712316]
66. Affan Denk,Kutbettin Demirdag,Ahmet Kalkan,Mehmet Ozden,Burhan Cetinkaya,Suleyman S Kilic.  (2015-02-26)  In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey..  Infectious diseases (London, England),  47  ((6)): (364-369).  [PMID:25712728]
67. Omid Tadjrobehkar,Hamid Abdollahi.  (2015-03-06)  A Novel Reduction Strategy of Clarithromycin Resistance in Helicobacter pylori..  Jundishapur journal of microbiology,  ((12)): (e13081-e13081).  [PMID:25741431]
68. Takashi Azuma,Hirotaka Ishiuchi,Tomomi Inoyama,Yusuke Teranishi,Misato Yamaoka,Takaji Sato,Yoshiki Mino.  (2015-07-17)  Occurrence and fate of selected anticancer, antimicrobial, and psychotropic pharmaceuticals in an urban river in a subcatchment of the Yodo River basin, Japan..  Environmental science and pollution research international,  22  ((23)): (18676-18686).  [PMID:26178832]
69. Barbara Gierlikowska,Wojciech Gierlikowski,Urszula Demkow.  (2020-10-06)  Alantolactone Enhances the Phagocytic Properties of Human Macrophages and Modulates Their Proinflammatory Functions..  Frontiers in pharmacology,  11  (1339-1339).  [PMID:33013371]
70. Xiaoyu Zhang, Peiran Meng, Wei Wang, Xiwen Li, Zuan Yang, Shaokai Du, Yue Sun.  (2023)  Simultaneous Electrochemical Determination of Erythromycin and Hemoglobin by Flexible Carbon Cloth Modified with ZnO Nanorod Arrays and Au Nanoparticles by Differential Pulse Voltammetry (DPV).  ANALYTICAL LETTERS,      [PMID:]
71. Qin Tang, Zhengcai Ma, Xiang Tang, Yan Liu, Huimin Wu, Yu Peng, Baihua Jiao, Rui Wang, Xiaoli Ye, Hang Ma, Xuegang Li.  (2023)  Coptisine inhibits Helicobacter pylori and reduces the expression of CagA to alleviate host inflammation in vitro and in vivo.  JOURNAL OF ETHNOPHARMACOLOGY,    (116618).  [PMID:37164257]
72. Ruoyu Deng, Dongxu Yang, Mengli Chen, Qiang He, Qingjuan He, Yi Chen.  (2023)  The enhancing energy efficiency of sulfadiazine degradation using a DBD-contact plasma treatment process.  CHEMICAL ENGINEERING JOURNAL,  463  (142491).  [PMID:]
73. Chong Yu, Chi Li, Ying Zhang, Xiang Du, Jing-Han Wang, Zhan-You Chi, Qian Zhang.  (2023)  Effects of environment-relevant concentrations of antibiotics on seawater Chlorella sp. biofilm in artificial mariculture effluent.  Algal Research-Biomass Biofuels and Bioproducts,  70  (103008).  [PMID:]
74. Yu Wang, Yunxiang He, Qin Wang, Xiaoling Wang, Blaise L. Tardy, Joseph J. Richardson, Orlando J. Rojas, Junling Guo.  (2023)  Microporous membranes for ultrafast and energy-efficient removal of antibiotics through polyphenol-mediated nanointerfaces.  Matter,  (260-273).  [PMID:]
75. Wan-Feng Xu, Yun Wang, Hai Huang, Jia-Wei Wu, Yuan Che, Chu-Jie Ding, Quan Zhang, Wei-Ling Cao, Li-Juan Cao.  (2022)  Octreotide-based therapies effectively protect mice from acute and chronic gastritis.  EUROPEAN JOURNAL OF PHARMACOLOGY,  928  (174976).  [PMID:35487253]
76. Ling Li, Yaoyao Du, Yang Wang, Ning He, Bing Wang, Tong Zhang.  (2022)  Atractylone Alleviates Ethanol-Induced Gastric Ulcer in Rat with Altered Gut Microbiota and Metabolites.  Journal of Inflammation Research,      [PMID:35996682]

Solution Calculators